Share Name Share Symbol Market Type Share ISIN Share Description
Relx Group LSE:REL London Ordinary Share GB00B2B0DG97 ORD 14 51/116P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +29.50p +1.98% 1,522.50p 1,524.50p 1,525.50p 1,526.00p 1,487.50p 1,491.50p 6,756,069 16:35:25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 7,355.0 1,734.0 82.2 18.5 16,210.73

Relx Share Discussion Threads

Showing 176 to 195 of 225 messages
Chat Pages: 9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
07/9/2012
13:09
Key Calls - Europe Nick Nelson............................ +44-20-756 81960 C.hanges to Key Calls Add Reed Elsevier NV We add Reed Elsevier NV to the European Key Call list. We believe that there are now clearer signs that the transformation underway at Reed Elsevier in recent years should allow it to deliver higher quality, resilient revenue, earnings and cash flow growth. In essence, the steps taken by senior management (be they restructuring or investment) are starting to deliver returns in terms of performance, and this should lead to greater returns for investors. In our view, this accelerating growth, and these improving returns, should justify a substantially higher valuation than the company currently attracts. We believe both the plc and NV lines offer scope for substantial outperformance, but we would advocate the NV over the plc, given the plc's p.remium to NV is near all-time highs at 11%. Cash returns – potential 7-8% annual cash yield Management recently announced that the proceeds from the Reed Business Information (RBI) disposals would be used for share buybacks – providing an indication of its likely strategy to maintain group leverage when it falls below 1.5x from 2013. Re-levering to that level in 2014 could add c9% to long-term earnings, or it could be maintained through smaller annual buybacks of £400-500m (3-4% of equity, a total 7-8% cash yield). For further details please see ".Reed Elsevier: Delivering returns" – Alastair Reid, 6 September 2012.
mechanical trader
05/9/2012
14:28
Joined you guys. Looks like the breakout is established. Some recent positive broker upgrades aswel.
mechanical trader
27/3/2012
11:09
http://www.independent.co.uk/news/business/analysis-and-features/publishers-be-damned-7544703.html
brain smiley
17/2/2012
13:03
http://www.ft.com/cms/s/0/2494fbc4-5873-11e1-9f28-00144feabdc0.html interesting
brain smiley
16/2/2012
13:03
LONDON (SHARECAST) - Nomura has reiterated its buy recommendation and 668p target for business information solutions provider Reed Elsevier, saying that the group's full-year results were "reassuring". The firm said that underlying sales growth was 2% in 2011, 3% excluding biennial cycling, compared with Nomura's 1.1% forecast. "The main differences were in Risk where growth was 4% vs. our 2.9% forecast and Exhibitions where growth was flat versus our -2% forecast," the broker said. "For 2012, the company expects continued growth in organic revenue. Consensus is around 2-2.5% and our current 1.3% estimate looks a touch conservative."
brain smiley
16/2/2012
10:29
Anglo-Dutch publisher Reed Elsevier, however, is heading in the other direction. Its shares have climbed 2p to 536p as it reported a 5% rise in annual operating profit and said it expected another year of growth despite the tricky economic climate. Singer Capital Markets said: Reed's full year results are ahead of expectations at the profit level. In broad terms the outlook is supportive of our positive stance on the business to business sector with exhibitions and data markets in generally good shape with some noteworthy deviations. We note that legal markets still look very tough and European exhibitions outlook appears soft and Reed is clearly cautious. Academic publishing commentary appears to be solid and non-European exhibitions is encouraging. The shares have lagged the market and only risen 2.9% year to date. The valuation looks modest and there is some scope for a re-rating.
brain smiley
18/4/2011
12:13
Surprised, thought the share price would build up towards reaching the XD date.
losses
12/4/2011
12:29
Am I pushing my luck with asking for a financial calendar to show main dates for results and dividend dates for 2011? It goes xdiv next wed with 15p per share. ta ;-)
losses
12/4/2011
12:29
There's also a promising article from PR Newswire today: "Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced the launch of Methods Navigator. This online research tool enables life scientists to search, access and apply the right method for their research, saving time and producing high-quality results. Methods Navigator joins Elsevier's stable of workflow solutions including Hazmat Navigator and the award-winning BrainNavigator." http://www.advfn.com/p.php?pid=nmona&article=47259228&symbol=L^REL
nasprey
12/4/2011
12:27
By all means Losses :)
nasprey
12/4/2011
12:18
Can you please add the long term chart.
losses
12/4/2011
10:40
NYSE: http://www.americanbankingnews.com/2011/04/11/reed-elsevier-plc-ruk-given-outperform-rating-by-zacks-investment-research-analysts/
nasprey
11/4/2011
16:47
Nothing wrong with it, just this one is from back in 2006 and the Title etc is not relevant and nobody seems to be looking at it. And for the same reasons that 'kantona' started this thread in 2006 rather than just carrying on from the 2003 thread: kantona - 13 Mar'06 "I have decided to commence a new thread ... to stimulate interest ..Those who study charts can see for the past few months it has been trading sideways between 505 -550 range ..looks to be heading back up to 550"
nasprey
11/4/2011
16:32
Whats wrong with using this existing thread? By the way Barclays tipped REL ages ago when share price was 570ish back in late January. Xdiv on these is next Wed 20th April and are paying 15p per share.
losses
11/4/2011
15:39
Thought i'd start a new Thread on this since the old one from 2006 was getting a little stale! Apologies for the spelling error in the thread title.... Doh! REED ELSEVIER just came up in an email Alert & my Barclays 'Stock Watch' as a Buy: Been doing some research on it today, seems interesting: 11th April 2011 - "Elsevier and Wood Mackenzie to Combine Scientific and Commercial Information Into Geofacets" http://m2m.tmcnet.com/news/2011/04/11/5436359.htm http://www.info.geofacets.com/faq
nasprey
11/4/2011
15:00
I started another thread on REL for those interested. http://www.advfn.com/cmn/fbb/thread.php3?id=25010243
nasprey
01/4/2011
15:04
REED Elsevier is a global name in publishing information and financial services. The group provides software to business, scientific and legal professionals and encompasses three core activities: its LexisNexis division (legal, tax and regulatory information); its Elsevier Division (scientific content); and its Reed Elsevier Division (producing online workflow tools). As the media sector recovers we believe that Reed could outperform its peers. A large portion of its earnings are generated in the US where the legal database market is strongest and we think fears of further weakening in the legal business are overdone. EXPRESS CASINO: GET A FREE BONUS OF UP TO £150 NOW! Revenue for this division should have reached a trough and confirmation of this should alleviate concerns in the market over the outlook. We also expect the firm to contain investment costs and believe that the overall earnings profile will improve. Reed's science division continues to deliver solid growth from its subscription model and we expect an improvement for some of the cyclical operations, such as its exhibitions activities. Reed's new CEO has started to sound more confident in a recovery and is not expected to make many changes. Management has also come out strongly on cost-saving targets and these measures, along with plans for reinvestment in the business, should allay some fears that Reed requires a "step up" in investment costs to combat increasing competition in the publishing sector. However, some risks remain in Reed's science & technology business activities, as there are concerns that a potentially free internet access model will mean a loss of market share – even though a successful free online model has not been developed.
losses
21/2/2011
07:55
iNVESTMENT CONCLUSION fiE HAVE REACHED THE STAGE OF THE ECONOMIC CYCLE WHERE WE BELIEVE rEED IS LIKELY TO OUTPERFORM ITS MEDIA PEERS AND ARE THEREFORE UPGRADING OUR RECOMMENDATION TO bUY. fiE HAVE SEEN THE FIRST SIGNS OF AN IMPROVEMENT IN THE MORE CYCLICAL OPERATIONS AND BELIEVE FEARS OF FURTHER WEAK TRADING IN THE lEGAL BUSINESS OVER OVERDONE. fiE EXPECT INVESTMENT COSTS TO BE CONSTRAINED, AND ALL OF THE ABOVE SHOULD IMPROVE THE EARNINGS PROFILE OF THE GROUP. oUR REVISED FAIR VALUE OF 660P IS BASED ON A SUM OF THE PARTS VALUATION. tHIS EQUATES TO A Pe OF 14.5X BASED ON 2011 EARNINGS. tHIS IS IN LINE WITH rEED'S LONG-TERM AVERAGE Pe MULTIPLE, WHICH LOOKS FAIR IN OUR VIEW, NOW THE CYCLE IS TURNING.
losses
28/1/2011
14:34
http://www.my-share.co.uk/Broker-notes-January-2011/ Broker upgrade today
nellie1973
21/11/2010
11:55
http://www.telegraph.co.uk/finance/newsbysector/banksandfinance/privateequity/8149016/Cinven-and-Apax-talk-to-Reed-over-buy-out.html
sajjad017
Chat Pages: 9  8  7  6  5  4  3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180222 04:45:35